Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients

Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients
复制标题

DOI:
10.1001/archsurg.143.1.62
复制
发表时间:
2008-01-01
影响因子:
--
通讯作者:
Arbogast, Patrick G.
Arbogast, Patrick G.
中科院分区:
其他
文献类型:
--
作者:
Cotton, Bryan A.;Guillamondegui, Oscar D.;Arbogast, Patrick G.

文献摘要

被引文献

相似文献

背景:肾上腺功能不全(AI)的及时诊断和治疗可显著降低创伤患者的死亡率.设计:回顾性登记研究,设置:学术一级创伤中心,患者:重症监护室的所有创伤患者,从2002年1月1日到2004年12月31日,他们接受了促肾上腺皮质激素刺激试验(CST),以推测AI。促肾上腺皮质激素刺激试验,其中反应定义为增加9 μ g/dL结果:137例危重创伤患者行CST检查,其中137例患者的皮质醇水平在248 nmol/L以上,137例患者的皮质醇水平在248 nmol/L以上,137例患者的皮质醇水平在248 nmol/L以上。83例(60.6%)为无应答者,54例(39.4%)为应答者。年龄、性别、种族、创伤机制、损伤严重度评分和修订的创伤评分在组间无统计学差异。两组的脓毒症/脓毒性休克、机械通气和死亡率也相似。然而,无应答组入院时出血性休克的发生率(45 [54%] vs 16 [30%])、血管加压药支持的需要率(65 [78%] vs 28 [52%])和咪哒唑胺暴露率(59 [71%] vs 28 [52%])均显著高于无应答组(P
Background:: Timely diagnosis and treatment of adrenal insufficiency (AI) dramatically reduces mortality in trauma patients. We sought to identify risk factors and populations with a high risk of developing AI.Design: Retrospective registry study.Setting: Academic level I trauma center.Patients: All trauma patients in the intensive care unit who underwent cosyntropin stimulation testing (CST) for presumed AI from January 1, 2002, through December 31, 2004.Intervention: Cosyntropin stimulation testing, in which response was defined as an increase of 9 mu g/dL (248 nmol/L) or more in cortisol level.Main Outcome Measure: Risk factors for developing AI in critically ill trauma patients.Results:: In 137 patients, CST was performed; 83 (60.6%) were nonresponders and 54 (39.4%) were responders. Age, sex, race, trauma mechanism, Injury Severity Score, and Revised Trauma Score were not statistically different between the groups. Rates of sepsis/septic shock, mechanical ventilation, and mortality were also similar between the 2 groups. However, rates of hemorrhagic shock on admission (45 [54%] vs 16 [30%]), requirement of vasopressor support (65 [78%] vs28 [52%]), andetomidateexposure (59 [71%] vs28 [52%]) were all significantly higher in the nonresponder group (P